Launch week offerEnds in00h00m00s

annual Promonthly Pro

Benjamin Rome

Assistant Professor of Medicine

Brigham and Women's Hospital

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Collaborators (3)

Aaron Mitchell

Assistant Attending

Memorial Sloan Kettering Cancer Center

UNITED STATES

Edward Cliff

Peter MacCallum Cancer Institute

Benjamin D. Sommers

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Benjamin Rome

Research Interests

Make your next move.

Explore related searches

Articles (20)

Collaborators (3)

Aaron Mitchell

Edward Cliff

Benjamin D. Sommers

Make your next move.

Benjamin Rome

Research Interests

Make your next move.

Explore related searches

Articles (20)

Pricing Trends and Overlapping Indications of Checkpoint Inhibitors for Cancer Treatment

Prescription Drugs Affected by an Expanded Rare Disease Carve-Out from Medicare Price Negotiation

Realizing Benefits of First‐in‐Class Generic Entry—The Case of SGLT2 Inhibitors

Using prescription drug data for timely assessments of state insurance coverage rates: a validation study

Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare

The Growing Success of Medicare Drug-Price Negotiation

Share of Sales Subject to Medicare Inflation Rebates and Price Increases of Top‐Selling Drugs

Generic Liraglutide — Overlooked but Not Forgotten

Medicare spending and use of subcutaneous biologic formulations with hyaluronidase

Association between changes in prices and out‐of‐pocket costs for brand‐name clinician‐administered drugs

Medicare’s First Round of Drug-Price Negotiation — Measuring Success

Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications

Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label

Medicare Negotiation’s Drug Reformulation Problem

Medicare Should Cover Weight Loss Drugs as Long as the Prices are Affordable

Reforming Pharmacy Benefit Managers — A Review of Bipartisan Legislation

Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022

Will Medicare Price Negotiation Delay Cancer-Drug Launches?

Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups

Market dynamics of authorized generics in Medicaid from 2014 to 2020

Collaborators (3)

Aaron Mitchell

Edward Cliff

Benjamin D. Sommers

Make your next move.